MILAN, ITALY — Amplifon reported continued growth and improved profitability in the third quarter of 2026, as the global hearing care retailer prepares for its planned acquisition of GN Hearing, a transaction that could significantly reshape its position in the hearing healthcare industry....
Continue reading at Hearing Health Matters
✦ The floor
Discussion
Signed responses from readers of the wire.
No actionable change — this is a financial and corporate news item with no direct clinical implications for audiologists at this time.
A combined Amplifon–GN Hearing entity would represent a major vertical integration in hearing healthcare, potentially reshaping brand availability, pricing, and competitive dynamics for independent clinics and dispensers worldwide.
- 01Amplifon reported Q3 2026 earnings growth and improved profitability.
- 02The planned acquisition of GN Hearing is progressing, pending regulatory approvals.
- 03The deal would vertically integrate a global retail hearing chain with a major hearing aid manufacturer.
- 04Consolidation at this scale could affect product availability and supplier relationships for independent clinics.
- 05No clinical or patient-outcome data are discussed in this financial report.
Amplifon reported earnings growth and improved profitability in Q3 2026.
press releasesupportedThe acquisition of GN Hearing will substantially expand Amplifon's market position in hearing healthcare.
press releasepartially supported
